About this FactMed analysis covering adverse side effect reports of ALFENTANIL patients who developed CELLULITIS.

FactMed provides MD-approved analysis to help both patients, researchers, and physicians accurately assess the risk profile for more than 20,000 different pharmaceutical products. The below report offers compiled information from Food & Drug Administration and FactMed user submissions. Between January 2004 and October 2012, 4 individuals taking ALFENTANIL reported CELLULITIS to the FDA. A total of 427 ALFENTANIL drug adverse event reaction reports were made with the FDA during this time period. Often the FDA only receives reports of the most critical and severe cases; these numbers may therefore underrepresent the complication rate of the medication.

FDA Research Report

Introduction This page is designed to help you determine the relationship, if any, between ALFENTANIL and CELLULITIS. In doing so, we compare ALFENTANIL with other drugs that cause CELLULITIS, to help you evaluate whether or not ALFENTANIL causes CELLULITIS. Likewise, this page shows the most highly-reported side effects of ALFENTANIL, so you can see if CELLULITIS ranks among ALFENTANIL's most well-known side effects.
Summary Statistics
Reports of ALFENTANIL causing CELLULITIS: 4
Reports of any side effect of ALFENTANIL : 427
Percentage of ALFENTANIL patients where CELLULITIS is a reported side effect: 0.9368%

FDA reports of any drug causing CELLULITIS : 18141
Average percentage for all medicated patients where CELLULITIS is reported as a complication: 0.1137%

Physician opinion on ALFENTANIL as adverse event culprit:

Overall opinion for all reports of this drug:
Most frequent diagnoses/indications for prescribing ALFENTANIL:
ANAESTHESIA ( 63 patients )
GENERAL ANAESTHESIA ( 52 patients )
SEDATION ( 17 patients )
DRUG USE FOR UNKNOWN INDICATION ( 16 patients )
INDUCTION OF ANAESTHESIA ( 16 patients )
OSTEOTOMY ( 15 patients )
PRODUCT USED FOR UNKNOWN INDICATION ( 13 patients )
PAIN ( 6 patients )
SENSORY DISTURBANCE ( 5 patients )
DRUG ABUSE ( 4 patients )
ANAESTHESIA PROCEDURE ( 3 patients )
IN VITRO FERTILISATION ( 3 patients )
DRUG WITHDRAWAL SYNDROME ( 2 patients )
ILL-DEFINED DISORDER ( 2 patients )
MUSCLE RELAXANT THERAPY ( 1 patients )
PNEUMONIA ( 1 patients )
DISCOMFORT ( 1 patients )
SURGERY ( 1 patients )
LIGHT ANAESTHESIA ( 1 patients )
PERIOPERATIVE ANALGESIA ( 1 patients )
POST PROCEDURAL PAIN ( 1 patients )
COLONOSCOPY ( 1 patients )
RETINAL DETACHMENT ( 1 patients )
VARICOSE VEIN OPERATION ( 1 patients )
( 0 patients )
Drugs with high FDA adverse event association with CELLULITIS:

FOSAMAX (4339 patients)
ASPIRIN (2084 patients)
VIOXX (2010 patients)
ZOMETA (1840 patients)
PREDNISONE (1623 patients)
LASIX (1484 patients)
AREDIA (1259 patients)
COUMADIN (1165 patients)
REMICADE (1110 patients)
HUMIRA (1102 patients)
METHOTREXATE (1077 patients)
AVONEX (1039 patients)
ENBREL (999 patients)
SEROQUEL (963 patients)
FOLIC ACID (922 patients)
LIPITOR (912 patients)
NEURONTIN (882 patients)
LISINOPRIL (869 patients)
FUROSEMIDE (865 patients)
PROTONIX (825 patients)
PRILOSEC (812 patients)
OXYCONTIN (804 patients)
SYNTHROID (796 patients)
ACCUTANE (792 patients)
PREDNISOLONE (750 patients)
OMEPRAZOLE (740 patients)
AMBIEN (737 patients)
DEXAMETHASONE (735 patients)
NEXIUM (713 patients)
LEVAQUIN (680 patients)
CELEBREX (675 patients)
ZOCOR (665 patients)
ZOLOFT (662 patients)
ATIVAN (650 patients)
POTASSIUM CHLORIDE (632 patients)
NORVASC (625 patients)
ALBUTEROL (614 patients)
VICODIN (594 patients)
PERCOCET (593 patients)
HEPARIN SODIUM INJECTION (582 patients)
ACETAMINOPHEN (564 patients)
ATENOLOL (556 patients)
PREVACID (548 patients)
ALLOPURINOL (545 patients)
XANAX (545 patients)
PLAVIX (542 patients)
ZOFRAN (532 patients)
TYSABRI (520 patients)
PREDNISONE TAB (519 patients)
DIGOXIN (516 patients)
SIMVASTATIN (516 patients)
DECADRON (514 patients)
MULTI-VITAMINS (492 patients)
REVLIMID (491 patients)
LANTUS (488 patients)
HYDROCHLOROTHIAZIDE (485 patients)
GABAPENTIN (478 patients)
LORAZEPAM (474 patients)
VANCOMYCIN (457 patients)
WARFARIN SODIUM (452 patients)
OXYCODONE HCL (442 patients)
DURAGESIC-100 (437 patients)
PAXIL (427 patients)
IBUPROFEN (426 patients)
ALENDRONATE SODIUM (423 patients)
LYRICA (421 patients)
LEXAPRO (416 patients)
VITAMIN D (413 patients)
LEVOTHYROXINE SODIUM (409 patients)
INSULIN (400 patients)
METFORMIN HCL (400 patients)
LORTAB (400 patients)
LOVENOX (394 patients)
TOPROL-XL (382 patients)
TOCILIZUMAB (381 patients)
CLINDAMYCIN (376 patients)
PROZAC (371 patients)
VELCADE (370 patients)
ACTONEL (369 patients)
ZYPREXA (369 patients)
MORPHINE (367 patients)
CALCIUM (362 patients)
CYMBALTA (362 patients)
COLACE (360 patients)
METOPROLOL TARTRATE (357 patients)
DIOVAN (353 patients)
CIPROFLOXACIN (348 patients)
EFFEXOR (346 patients)
THALIDOMIDE (341 patients)
KEFLEX (338 patients)
AUGMENTIN '125' (338 patients)
ZANTAC (338 patients)
FORTEO (336 patients)
REGLAN (336 patients)
ACTEMRA (336 patients)
AMOXICILLIN (333 patients)
NITROGLYCERIN (331 patients)
SINGULAIR (326 patients)
FLEXERIL (321 patients)
CYCLOPHOSPHAMIDE (319 patients)
DIANEAL (317 patients)
FOSAMAX PLUS D (308 patients)
FEMARA (306 patients)
ARANESP (306 patients)
COREG (305 patients)
DILAUDID (302 patients)
FLAGYL (301 patients)
PREMARIN (301 patients)
ASCORBIC ACID (299 patients)
COMPAZINE (298 patients)
BACTRIM (296 patients)
MS CONTIN (290 patients)
AMLODIPINE (289 patients)
HEPARIN (287 patients)
BONIVA (287 patients)
ZYRTEC (283 patients)
KLONOPIN (282 patients)
HUMALOG (280 patients)
WELLBUTRIN (279 patients)
PERIDEX (278 patients)
NYSTATIN (277 patients)
CLONAZEPAM (273 patients)
REBIF (272 patients)
CRESTOR (272 patients)
ADVAIR DISKUS 100/50 (271 patients)
FENTANYL (271 patients)
[THERAPY UNSPECIFIED] (270 patients)
CYCLOSPORINE (270 patients)
ALLEGRA (269 patients)
CELEXA (268 patients)
ACYCLOVIR (266 patients)
CEPHALEXIN (264 patients)
NAPROXEN (262 patients)
MORPHINE SULFATE (262 patients)
LOPRESSOR (262 patients)
DIFLUCAN (261 patients)
CALCIUM CARBONATE (260 patients)
CIPRO (259 patients)
SPIRONOLACTONE (259 patients)
GLUCOPHAGE (256 patients)
XELODA (251 patients)
TRAMADOL HCL (250 patients)
PEPCID (247 patients)
TAXOTERE (244 patients)
FLUCONAZOLE (244 patients)
VITAMIN E (242 patients)
ALPRAZOLAM (241 patients)
MULTI-VITAMIN (241 patients)
EXJADE (240 patients)
TAMOXIFEN CITRATE (239 patients)
NEUPOGEN (238 patients)
CLONIDINE (238 patients)
FERROUS SULFATE TAB (235 patients)
TRAZODONE HCL (235 patients)
ZITHROMAX (232 patients)
METOPROLOL (232 patients)
LANSOPRAZOLE (231 patients)
CHEMOTHERAPEUTICS NOS (230 patients)
ELAVIL (230 patients)
FLUOROURACIL (230 patients)
ADRIAMYCIN PFS (229 patients)
ARIMIDEX (228 patients)
AMITRIPTYLINE HCL (228 patients)
ONDANSETRON (228 patients)
PRAVACHOL (227 patients)
BACLOFEN (225 patients)
CALCIUM (UNSPECIFIED) (224 patients)
BYETTA (223 patients)
ACTOS (222 patients)
PROCRIT (222 patients)
VALIUM (221 patients)
BETASERON (220 patients)
SOLIRIS (219 patients)
CLOZARIL (217 patients)
EPOGEN (216 patients)
GLYBURIDE (215 patients)
VINCRISTINE (214 patients)
MYCOPHENOLATE MOFETIL (213 patients)
VITAMIN B-12 (212 patients)
FASLODEX (211 patients)
CYTOXAN (211 patients)
GEMZAR (210 patients)
FLONASE (210 patients)
OXYCODONE (209 patients)
POTASSIUM (209 patients)
FAMOTIDINE (206 patients)
TYLENOL (206 patients)
ALDACTONE (204 patients)
AVANDIA (203 patients)
RANITIDINE (203 patients)
DOXYCYCLINE (202 patients)
AVELOX (202 patients)
ULTRAM (202 patients)
MAGNESIUM OXIDE (201 patients)
CARBOPLATIN (201 patients)
GLIPIZIDE (198 patients)
TYLENOL (CAPLET) (198 patients)
BENADRYL (197 patients)
PLAQUENIL (197 patients)
AMARYL (197 patients)
RISPERDAL (195 patients)
METRONIDAZOLE (195 patients)
HYDROCODONE (193 patients)
FLOMAX (192 patients)
DEPAKOTE (192 patients)
RADIATION THERAPY (190 patients)
DARVOCET-N 100 (189 patients)
COZAAR (188 patients)
DIAZEPAM (188 patients)
PROMETHAZINE (187 patients)
Most common side effects for patients taking ALFENTANIL:
DRUG INTERACTION (75 patients)
DYSTONIA (56 patients)
MYOTONIA (54 patients)
RENAL IMPAIRMENT (42 patients)
SINUS TACHYCARDIA (34 patients)
AGITATION (32 patients)
BACK PAIN (28 patients)
TOXIC EPIDERMAL NECROLYSIS (28 patients)
INFECTION (26 patients)
CARDIAC ARREST (26 patients)
DRUG WITHDRAWAL SYNDROME (26 patients)
THERAPEUTIC AGENT TOXICITY (24 patients)
DRUG EFFECT DECREASED (24 patients)
BRADYCARDIA (23 patients)
TACHYCARDIA (19 patients)
MYOCLONUS (19 patients)
STARING (19 patients)
ANAPHYLACTIC SHOCK (18 patients)
HYPOTENSION (18 patients)
DRUG TOXICITY (18 patients)
MULTI-ORGAN FAILURE (17 patients)
VENTRICULAR FIBRILLATION (16 patients)
BRONCHOSPASM (16 patients)
DEATH (16 patients)
ALANINE AMINOTRANSFERASE INCREASED (15 patients)
OXYGEN SATURATION DECREASED (15 patients)
DRUG EXPOSURE DURING PREGNANCY (15 patients)
HEPATITIS (15 patients)
RESTLESSNESS (14 patients)
PANIC REACTION (14 patients)
LIVER FUNCTION TEST ABNORMAL (14 patients)
ABDOMINAL PAIN (13 patients)
WHITE BLOOD CELL COUNT INCREASED (13 patients)
TUBULOINTERSTITIAL NEPHRITIS (13 patients)
DRUG INEFFECTIVE (13 patients)
DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS (13 patients)
ANAPHYLACTIC REACTION (12 patients)
HYPERHIDROSIS (12 patients)
NAUSEA (12 patients)
RENAL FAILURE ACUTE (12 patients)
GASTROINTESTINAL HAEMORRHAGE (12 patients)
OEDEMA PERIPHERAL (12 patients)
AGGRESSION (11 patients)
COMA (11 patients)
CYANOSIS (11 patients)
ESCHERICHIA INFECTION (11 patients)
SOMNOLENCE (11 patients)
HAEMOGLOBIN DECREASED (11 patients)
PLEURAL EFFUSION (10 patients)
BLOOD PHOSPHORUS INCREASED (10 patients)
HYPERVENTILATION (10 patients)
CONDITION AGGRAVATED (10 patients)
DISEASE PROGRESSION (10 patients)
HYPOXIA (10 patients)
FEELING ABNORMAL (10 patients)
PULMONARY OEDEMA (9 patients)
SPEECH DISORDER (9 patients)
MYALGIA (9 patients)
ATRIAL FIBRILLATION (9 patients)
PILOERECTION (9 patients)
CAESAREAN SECTION (9 patients)
SEROTONIN SYNDROME (9 patients)
CATATONIA (9 patients)
POST PROCEDURAL COMPLICATION (9 patients)
DYSPNOEA (9 patients)
MYDRIASIS (9 patients)
HEPATIC FAILURE (9 patients)
ACUTE RESPIRATORY DISTRESS SYNDROME (8 patients)
AKATHISIA (8 patients)
ANAESTHETIC COMPLICATION (8 patients)
LACERATION (8 patients)
BLOOD ALBUMIN DECREASED (8 patients)
BLOOD BILIRUBIN INCREASED (8 patients)
BLOOD CALCIUM INCREASED (8 patients)
BRAIN OEDEMA (8 patients)
PNEUMONIA (8 patients)
PUPILLARY REFLEX IMPAIRED (8 patients)
ELECTROCARDIOGRAM QT PROLONGED (8 patients)
RHABDOMYOLYSIS (8 patients)
BLISTER (7 patients)
BLOOD ALKALINE PHOSPHATASE INCREASED (7 patients)
BLOOD CREATINE PHOSPHOKINASE INCREASED (7 patients)
HYPERSENSITIVITY (7 patients)
PYREXIA (7 patients)
C-REACTIVE PROTEIN INCREASED (7 patients)
PARAESTHESIA (7 patients)
VOMITING (7 patients)
PREMATURE RUPTURE OF MEMBRANES (7 patients)
SCLERODERMA (7 patients)
RENAL FAILURE (7 patients)
EXTENSOR PLANTAR RESPONSE (7 patients)
FATIGUE (7 patients)
HAEMATEMESIS (7 patients)
SLEEP DISORDER (7 patients)
PREMATURE LABOUR (7 patients)
ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED (6 patients)
AMNESIA (6 patients)
PEMPHIGOID (6 patients)
PROCEDURAL COMPLICATION (6 patients)
ASCITES INFECTION (6 patients)
ASPARTATE AMINOTRANSFERASE INCREASED (6 patients)
HYPOCOAGULABLE STATE (6 patients)
BLOOD PRESSURE DECREASED (6 patients)
IDIOPATHIC THROMBOCYTOPENIC PURPURA (6 patients)
VENTRICULAR TACHYCARDIA (6 patients)
HYPERGLYCAEMIA (6 patients)
WOUND SECRETION (6 patients)
ENTEROCOCCAL INFECTION (6 patients)
MOVEMENT DISORDER (6 patients)
SEPSIS (6 patients)
NO THERAPEUTIC RESPONSE (6 patients)
GLASGOW COMA SCALE ABNORMAL (6 patients)
ABDOMINAL SEPSIS (5 patients)
HYPOTONIA (5 patients)
HYPERREFLEXIA (5 patients)
APHASIA (5 patients)
ASCITES (5 patients)
HYPERPARATHYROIDISM (5 patients)
HYPOKALAEMIA (5 patients)
CARDIO-RESPIRATORY ARREST (5 patients)
UNRESPONSIVE TO STIMULI (5 patients)
THROMBOCYTOPENIA (5 patients)
PROPOFOL INFUSION SYNDROME (5 patients)
ELECTROCARDIOGRAM ST SEGMENT DEPRESSION (5 patients)
SCREAMING (5 patients)
ISCHAEMIC STROKE (5 patients)
FALL (5 patients)
GAMMA-GLUTAMYLTRANSFERASE INCREASED (5 patients)
TREMOR (5 patients)
HEMIPLEGIA (5 patients)
SMALL INTESTINAL HAEMORRHAGE (5 patients)
NEUTROPENIA (4 patients)
ACCIDENTAL OVERDOSE (4 patients)
RESUSCITATION (4 patients)
AIRWAY COMPLICATION OF ANAESTHESIA (4 patients)
TRANSAMINASES INCREASED (4 patients)
ARRHYTHMIA (4 patients)
ARTHRALGIA (4 patients)
NO ADVERSE EVENT (4 patients)
BLOOD TRIGLYCERIDES INCREASED (4 patients)
INJURY (4 patients)
MATERNAL DRUGS AFFECTING FOETUS (4 patients)
RESPIRATORY DEPRESSION (4 patients)
MOTOR DYSFUNCTION (4 patients)
MUSCLE RIGIDITY (4 patients)
LABILE BLOOD PRESSURE (4 patients)
CELLULITIS (4 patients)
DELAYED RECOVERY FROM ANAESTHESIA (4 patients)
DEPRESSED LEVEL OF CONSCIOUSNESS (4 patients)
HYPERTENSION (4 patients)
INTERNATIONAL NORMALISED RATIO INCREASED (4 patients)
DISSEMINATED INTRAVASCULAR COAGULATION (4 patients)
PULMONARY EMBOLISM (4 patients)
ECTOPIC PREGNANCY (4 patients)
RASH ERYTHEMATOUS (4 patients)
MELAENA (4 patients)
FOETAL MALPRESENTATION (4 patients)
NEUTROPHILIA (4 patients)
GRAND MAL CONVULSION (4 patients)
SUBARACHNOID HAEMORRHAGE (4 patients)
OEDEMA (4 patients)
ABORTION INDUCED (3 patients)
ANHEDONIA (3 patients)
VARICOSE VEIN OPERATION (3 patients)
PAIN (3 patients)
ANXIETY (3 patients)
APALLIC SYNDROME (3 patients)
MICROSTOMIA (3 patients)
RESPIRATORY FAILURE (3 patients)
BLOOD CREATININE INCREASED (3 patients)
UNEVALUABLE EVENT (3 patients)
PANIC ATTACK (3 patients)
BLOOD POTASSIUM DECREASED (3 patients)
BONE DISORDER (3 patients)
BRAIN DEATH (3 patients)
CARDIAC DISORDER (3 patients)
METABOLIC ACIDOSIS (3 patients)
SKIN REACTION (3 patients)
PANCREATIC ABSCESS (3 patients)
CEREBRAL HAEMORRHAGE (3 patients)
CEREBRAL ISCHAEMIA (3 patients)
CEREBROVASCULAR ACCIDENT (3 patients)
CHOLESTASIS (3 patients)
ORGAN FAILURE (3 patients)
PANCREATITIS (3 patients)
CONVULSION (3 patients)
CYTOLYTIC HEPATITIS (3 patients)
TUMOUR LYSIS SYNDROME (3 patients)
PANCREATIC NECROSIS (3 patients)
DEHYDRATION (3 patients)
DEPRESSION (3 patients)
PROTHROMBIN TIME PROLONGED (3 patients)
DRUG HYPERSENSITIVITY (3 patients)
HYPOGLYCAEMIA NEONATAL (3 patients)
DYSPHASIA (3 patients)
DYSPHONIA (3 patients)
RENAL INJURY (3 patients)
LOCALISED OEDEMA (3 patients)
ELECTROMECHANICAL DISSOCIATION (3 patients)
RAYNAUD'S PHENOMENON (3 patients)
ERYTHEMA (3 patients)
FACE OEDEMA (3 patients)
FEAR (3 patients)
SEX CHROMOSOME ABNORMALITY (3 patients)
SKIN DISCOLOURATION (3 patients)
GENERAL PHYSICAL HEALTH DETERIORATION (3 patients)
HAEMATOMA (3 patients)
HAEMODIALYSIS (3 patients)
THERAPY NON-RESPONDER (3 patients)
HEART RATE INCREASED (3 patients)

In addition to reviewing our up-to-date FDA research, users may interact with the FactMed community - currently one million members and growing! FactMed online research and discussions are read by patients, scientists, physicians, and other interested health care parties. Post follow up Questions to learn from our diverse readership. Likewise, patients who have experienced unwanted effects are encouraged to share their Concerns to help educate and inform our members.


Recent FactMed Activity for ALFENTANIL


Issue Description / Topic Timestamp

My Patient Resources

Get your questions answered! Over one million patients, researchers, and health care providers have visited FactMed. If you have a question about CELLULITIS and ALFENTANIL, post it here. You may receive a response from a fellow patient - or a leading expert in the field.
Your Question:

Share your experience: Over one million patients, researchers, and health care providers have visited FactMed. If you have a noteworthy experience as a patient taking ALFENTANIL, post it here. Your story could help a fellow patient - or provide insight to a leading expert in the field.
Your Experience or Concern:

Telemedicine Expert Consults FactMed newest feature allows patients to consult - via realtime videoconferencing - experts in ALFENTANIL. This premium feature connects patients to experts, regardless of geography. FactMed experts charge reasonable rates that may be reimbursable by your insurance as a second-opinion.
We are currently accepting registration for ALFENTANIL experts. If you are a healthcare provider experienced in prescribing ALFENTANIL, please register here.

Your online appointment book for Choudrant Rentals & Services

Chef and Catering services in Choudrant
Chiropracter and Massage services in Choudrant
Event and Wedding Planning services in Choudrant
Hair Styling services in Choudrant
Personal Shopping services in Choudrant
Photography and Videography services in Choudrant
Private Investigation services in Choudrant
Website Design services in Choudrant

Home
Appliance Repair services in Choudrant
Appraisals services in Choudrant
Awnings services in Choudrant
Builder Services services in Choudrant
Carpentry services in Choudrant
Cleaning services in Choudrant
Decks and Porches services in Choudrant
Electricians services in Choudrant
Fireplace services in Choudrant
Generators services in Choudrant
Greenhouses and Nurseries services in Choudrant
Handymen services in Choudrant
Home Security services in Choudrant
HVAC services in Choudrant
Insulation services in Choudrant
Interior Design services in Choudrant
Landscaping services in Choudrant
Lawn and Yard services in Choudrant
Locksmiths services in Choudrant
Marble and Granite Experts services in Choudrant
Masonry services in Choudrant
Moving Services services in Choudrant
Painters services in Choudrant
Plumbing services in Choudrant
Pool and Spa services in Choudrant
Property Management services in Choudrant
Roofers services in Choudrant
Snow Plowing services in Choudrant
Solar Power Consultants services in Choudrant
Upholstery services in Choudrant
Wallpaper services in Choudrant
Waterproofing services in Choudrant
Windows services in Choudrant
Services - Other



© 2014 FactMed, Inc
Privacy Policy
Terms of Use